Gossamer Bio Faces Investor Lawsuit Deadline as Rosen Law Firm Urges Affected Shareholders to Act Roivant Shares Surge as Company Reports Swing to Profitability Key Economic Data and Corporate Earnings Set to Shape Market Sentiment This Week Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook Retail Sales Data A Key Gauge of Consumer Spending and Economic Health Arrowhead Pharmaceuticals Presents Plozasiran Data on Renal and Hepatic Impairment GCI Liberty Inc GLIBA Q1 2026 Earnings Massive EPS Miss Sinks Shares JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path FFWM Q4 2025 Earnings EPS Misses Estimates as Bank Faces Headwinds Shares Edge Higher UPLD Q1 2026 Earnings EPS Surges Past Expectations Stock Reacts Positively Uxin Q1 2025 Earnings Widening Losses and Stock Decline Highlight Persistent Challenges Guardian Pharmacy Services Q1 2026 Earnings EPS Misses Estimates Amid Modest Market Response iQSTEL IQST Sheds Over 4 as Stock Tests Critical Support Zone Eaton Vance Municipal Income 2028 Term Trust ETX Hovers Near Support Amid Minimal Volatility Camping World Holdings CWH Extends Decline as Recreational Vehicle Demand Remains Under Pressure Galata Acquisition Corp II Warrants Hold Steady at 030 as Key Levels Remain Defined Wintergreen Acquisition Corp WTG Holds Steady at 1035 Assessing the Stalemate in a SPAC Shell April Jobs Report Preview Labor Market Cooling But Resilient Economists Say QT Imaging Q1 2026 Earnings Wide EPS Miss and No Revenue Reported Weigh on Investor Sentiment EZGO Technologies Slips 292 as Stock Tests Key Support at 126 Velocity Financial Q1 2026 Earnings EPS Surpasses Estimates with 52 Beat SLN Q4 2024 Earnings Positive EPS Surprise Drives Stock Rally Amid Revenue Absence SLI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress FNGR Q4 2024 Earnings EPS Misses Estimates as Company Navigates Transition JOE Q1 2026 Earnings Reported EPS of 024 Amid Quiet Quarter Shares Edge Lower NTRS Q1 2026 Earnings EPS Surges 143 Above Estimates Amid Solid Operating Performance ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances